Add BrightSurf on Google Email

Higher risk of heart failure in cold weather, study suggests

A study found that cold temperatures and atmospheric pressure increases are associated with a higher risk of hospitalization and death in elderly patients with heart failure. The researchers suggest that elderly patients should avoid fog and low cloud weather in winter to prevent such events.

SourceElsevier·JournalEnvironment International·DateSep 26, 2017

New understanding of how muscles work

A new technique developed at McGill University has made it possible to study the behavior of individual sarcomeres in muscles. The researchers found that neighboring sarcomeres adjust to the activation of one single sarcomere, leading to a cooperative mechanism that is crucial for understanding muscle contraction.

SourceMcGill University·JournalProceedings of the National Academy of Sciences·DateAug 23, 2017

In utero exposure to diesel exhaust could be linked to adult heart failure

A new study published in The FASEB Journal reveals that gestational exposure to diesel exhaust can modify DNA in the developing embryo and increase susceptibility to adult heart failure. Researchers identified specific gene expression effects and DNA methylation changes that may play a role in mediating adult sensitivity to heart failure.

Age and obesity conspire to damage the tiny blood vessels that feed the heart, causing heart failure

A study found that age and obesity create a perfect storm that damages the tiny blood vessels that directly feed the heart muscle, leading to reduced blood flow and increased risk of heart failure. The inflammation caused by both factors thickens the walls of these microvasculature, making them less able to dilate and sustain the heart.

Temple researchers identify novel mechanism underlying efficacy of common heart failure drug

Researchers at Temple University have identified a novel mechanism underlying the efficacy of common heart failure drug beta-blockers. The study reveals that dysfunctional beta-adrenergic receptor 3 and decreased levels of cardioprotective phospholipid sphingosine 1-phosphate contribute to treatment resistance in some patients.

SourceTemple University Health System·JournalJournal of the American College of Cardiology·DateJul 3, 2017